TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,536,717 | +334.1% | 129,900 | +117.2% | 0.22% | +825.0% |
| Q3 2022 | $354,008 | +178.7% | 59,800 | +100.0% | 0.02% | +60.0% |
| Q2 2022 | $127,000 | -75.9% | 29,900 | -46.0% | 0.02% | 0.0% |
| Q1 2022 | $527,000 | -66.6% | 55,400 | -33.3% | 0.02% | -53.1% |
| Q4 2021 | $1,579,000 | -30.0% | 83,100 | +22.6% | 0.03% | -52.9% |
| Q3 2021 | $2,256,000 | +17.7% | 67,771 | +37.2% | 0.07% | 0.0% |
| Q2 2021 | $1,917,000 | +184.0% | 49,400 | +252.9% | 0.07% | +300.0% |
| Q1 2021 | $675,000 | -93.4% | 14,000 | -92.9% | 0.02% | -91.3% |
| Q4 2020 | $10,196,000 | +451.1% | 196,000 | +183.7% | 0.20% | +182.6% |
| Q3 2020 | $1,850,000 | +374.4% | 69,094 | +245.5% | 0.07% | +165.4% |
| Q2 2020 | $390,000 | -68.8% | 20,000 | -86.1% | 0.03% | -81.2% |
| Q2 2019 | $1,250,000 | – | 144,400 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |